Hyperkalemia induced by the calcium channel blocker, benidipine

被引：10
|
作者：
Imamura, T [1 ]
Matsuura, Y [1 ]
Nagoshi, T [1 ]
Ishikawa, T [1 ]
Date, H [1 ]
Kita, T [1 ]
Matsuyama, A [1 ]
Matsuo, T [1 ]
Eto, T [1 ]
机构：
[1] Miyazaki Med Coll, Dept Internal Med 1, Miyazaki 8891692, Japan
来源：
INTERNAL MEDICINE | 2003年 / 42卷 / 06期
关键词：
hyperkalemia; benidipine; calcium channel blocker; potassium; side effect;
D O I：
10.2169/internalmedicine.42.503
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 73-year-old hypertensive, non-diabetic woman without obvious renal dysfunction had frequently been hyperkalemic over four years after receiving antihypertensive drugs including the calcium channel blocker (CCB) benidipine. One week after all medications were accidentally discontinued, the serum potassium level returned to normal. After we obtained the informed consent of the patient, benidipine alone was administered again for over two weeks and hyperkalemia developed once more. This previously uncommon side effect of hyperkalemia induced by benidipine is not very serious but it is apt to be overlooked. Since CCBs are now widely prescribed, the development of hyperkalemia should be considered.
引用
收藏
页码：503 / 506
页数：4
相关论文
共 50 条
  • [1] The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta
    Makoto Takayama
    Kozo Yao
    Michihito Wada
    Journal of Biomedical Science, 16
  • [2] The dihydropyridine calcium channel blocker benidipine prevents lysophophatidylcholine-induced endothelial dysfunction in rat aorta
    Takayama, Makoto
    Yao, Kozo
    Wada, Michihito
    JOURNAL OF BIOMEDICAL SCIENCE, 2009, 16
  • [3] Spotted fever rickettsia-induced microvascular endothelial barrier dysfunction is delayed by the calcium channel blocker benidipine
    Kim, Yuri
    Clemens, Emily G.
    Farner, Jennifer M.
    Londono-Barbaran, Andres
    Grab, Dennis J.
    Dumler, J. Stephen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 663 : 96 - 103
  • [4] Benidipine, a calcium channel blocker, regulates proliferation and phenotype of vascular smooth muscle cells
    Arakawa, E
    Hasegawa, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 (02) : 149 - 156
  • [5] Benidipine calcium channel blocker promotes the death of cigarette smoke-induced senescent cells and improves lung emphysema
    Palazzo, Alberta
    Makulyte, Gabriela
    Goerhig, Delphine
    Medard, Jean-Jacques
    Gros, Vincent
    Trottein, Francois
    Adnot, Serge
    Vindrieux, David
    Flaman, Jean-Michel
    Bernard, David
    AGING-US, 2023, 15 (23): : 13581 - 13592
  • [6] A calcium-channel blocker, benidipine, improves forearm reactive hyperemia in patients with essential hypertension
    Makino, H
    Aoki, M
    Hashiya, N
    Yamasaki, K
    Shimizu, H
    Miwa, K
    Ogihara, T
    Morishita, R
    BLOOD PRESSURE, 2005, 14 : 39 - 44
  • [7] Renoprotective effect of a calcium channel blocker, benidipine, in combination with an angiotensin II receptor blocker in hypertensive patients with chronic kidney disease
    Dohi, Y.
    Miyagawa, K.
    Nakazawa, A.
    Kimura, G.
    JOURNAL OF HYPERTENSION, 2008, 26 : S515 - S515
  • [8] Effects of the T/L-type calcium channel blocker, benidipine on albuminuria plasma and aldosterone concentration: A pilot study of switching from l-type calcium channel blockers to benidipine
    Tani, S.
    Nagao, K.
    Hirayama, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 67 - 67
  • [9] Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker
    Yao, K
    Nagashima, K
    Miki, H
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 (04) : 243 - 261
  • [10] Benidipine, a dihydropyridine-calcium channel blocker, inhibits lysophosphatidylcholine-induced endothelial injury via stimulation of nitric oxide release
    Matsubara, M
    Yao, K
    Hasegawa, K
    PHARMACOLOGICAL RESEARCH, 2006, 53 (01) : 35 - 43
12345